Table 3.
Multivariate* logistic regression for factors associated with device explantation within 90 days
Artificial Urinary Sphincter | Inflatable Penile Prosthesis | |||||
---|---|---|---|---|---|---|
| ||||||
OR | 95% CI | P | OR | 95% CI | P | |
Age | 1.03 | 1.007–1.05 | <0.01 | 0.99 | 0.99–1.01 | 0.33 |
| ||||||
Hypertension | 0.96 | 0.67–1.39 | 0.83 | 1.03 | 0.77–1.36 | 0.85 |
| ||||||
PVD | 1.13 | 0.39–3.24 | 0.83 | 1.05 | 0.54–2.04 | 0.88 |
| ||||||
LOS ≥ 24 hrs (ref <24 hrs) | 0.90 | 0.52–1.23 | 0.31 | 1.39 | 0.98–1.96 | 0.06 |
| ||||||
Diabetes | 1.86 | 1.28–2.72 | <0.01 | 1.59 | 1.14–2.21 | <0.01 |
| ||||||
CAD | 1.48 | 0.99–2.20 | 0.06 | 1.31 | 0.95–1.83 | 0.10 |
| ||||||
Neurologic condition** | 2.42 | 0.80–7.30 | 0.12 | 1.04 | 0.25–4.29 | 0.96 |
| ||||||
CCI (ref = 0) | ||||||
1 | 1.18 | 0.65–2.16 | 0.59 | 1.12 | 0.80–1.58 | 0.50 |
>1 | 1.71 | 0.94–3.13 | 0.06 | 1.22 | 0.83–1.80 | 0.30 |
| ||||||
Prior Device | 1.02 | 0.51–2.01 | 0.96 | 3.32 | 1.58–6.99 | <0.01 |
| ||||||
PO Antibiotic duration (days) | 1.01 | 0.97–1.05 | 0.54 | 1.03 | 1.002–1.05 | 0.03 |
| ||||||
PO antibiotics (ref = none) | ||||||
Fluoroquinolones¶ | 1.13 | 0.66–1.93 | 0.66 | 0.91 | 0.61–1.36 | 0.64 |
Trimethoprim-Sulfamethoxazole | 0.42 | 0.14–1.26 | 0.12 | 1.06 | 0.58–1.94 | 0.85 |
Cephalexin | 0.68 | 0.36–1.30 | 0.25 | 1.01 | 0.65–1.58 | 0.96 |
Amoxicillin-Clavulanate | 1.08 | 0.39–2.99 | 0.89 | 1.69 | 0.89–3.30 | 0.11 |
Other£ | 0.83 | 0.24–2.94 | 0.78 | 0.73 | 0.34–2.34 | 0.59 |
CAD- coronary artery disease, PVD- peripheral vascular disease, LOS – length of stay, CCI – Charlson comorbidity index
Controlling for geographic region and year
Neurologic condition includes autonomic disorders, multiple sclerosis, para- and quadriplegia, cauda equina pathology, spinal cord injury (all levels), neurogenic bladder, muscular atrophy, spina bifida, nerve root injury
Ciprofloxacin or levofloxacin
All antibiotics received by fewer than 100 patients (cefpodoxime, nitrofurantoin, tetracycline, macrolide, penicillin)